The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Azithromycin and the Risk of Cardiovascular Death
Open accessAbstract
BACKGROUND: Although several macrolide antibiotics are proarrhythmic and associated with an increased risk of sudden cardiac death, azithromycin is thought to have minimal cardiotoxicity. However, published reports of arrhythmias suggest that azithromycin may increase the risk of cardiovascular death. METHODS: We studied a Tennessee Medicaid cohort designed to detect an increased risk of death related to short-term cardiac effects of medication, excluding patients with serious noncardiovascular illness and person-time during and shortly after hospitalization. The cohort included patients who took azithromycin (347,795 prescriptions), propensity-score-matched persons who took no antibiotics (1,391,180 control periods), and patients who took amoxicillin (1,348,672 prescriptions), ciprofloxacin (264,626 prescriptions), or levofloxacin (193,906 prescriptions). RESULTS: During 5 days of therapy, patients taking azithromycin, as compared with those who took no antibiotics, had an increased risk of cardiovascular death (hazard ratio, 2.88; 95% confidence interval [CI], 1.79 to 4.63; P<0.001) and death from any cause (hazard ratio, 1.85; 95% CI, 1.25 to 2.75; P=0.002). Patients who took amoxicillin had no increase in the risk of death during this period. Relative to amoxicillin, azithromycin was associated with an increased risk of cardiovascular death (hazard ratio, 2.49; 95% CI, 1.38 to 4.50; P=0.002) and death from any cause (hazard ratio, 2.02; 95% CI, 1.24 to 3.30; P=0.005), with an estimated 47 additional cardiovascular deaths per 1 million courses; patients in the highest decile of risk for cardiovascular disease had an estimated 245 additional cardiovascular deaths per 1 million courses. The risk of cardiovascular death was significantly greater with azithromycin than with ciprofloxacin but did not differ significantly from that with levofloxacin. CONCLUSIONS: During 5 days of azithromycin therapy, there was a small absolute increase in cardiovascular deaths, which was most pronounced among patients with a high baseline risk of cardiovascular disease. (Funded by the National Heart, Lung, and Blood Institute and the Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
The pharmacokinetics of azithromycin in human serum and tissues
Foulds, G., Shepard, R. M., & Johnson, R. B. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.suppl_a.73 · Cited by 755
Indications for propensity scores and review of their use in pharmacoepidemiology
Glynn, R. J., Schneeweiss, S., & Stürmer, T. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_293.x · Cited by 541
Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes
Ray, W. A., Murray, K. T., Meredith, S., Narasimhulu, S. S., Hall, K., & Stein, C. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040582 · Cited by 496
Self-citationKannankeril, P., Roden, D. M., & Darbar, D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003723 · Cited by 440
Recall Accuracy for Prescription Medications: Self-report Compared with Database Information
West, S. L., Savitz, D. A., Koch, G., Strom, B. L., Guess, H. A., & Hartzema, A. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117563 · Cited by 352
USE OF MEDICAID DATA FOR PHARMACOEPIDEMIOLOGY
RAY, W. A., & GRIFFIN, M. R. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115198 · Cited by 315
Self-citationDrug‐ and non‐drug‐associated QT interval prolongation
Van Noord, C., Eijgelsheim, M., & Stricker, B. H. C. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03660.x · Cited by 264
Cited by
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
(2015) · Europace · doi:10.1093/europace/euv319 · Cited by 1,592
Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31180-6 · Cited by 1,200
RetractedBhimraj, A., Morgan, R. L., Shumaker, A. H., Lavergne, V., Baden, L., Cheng, V. C.-C., Edwards, K. M., Gandhi, R., Muller, W. J., O’Horo, J. C., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa478 · Cited by 1,033
International Consensus Statement on Allergy and Rhinology: Rhinosinusitis
Orlandi, R. R., Kingdom, T. T., Hwang, P. H., Smith, T. L., Alt, J. A., Baroody, F. M., Batra, P. S., Bernal‐Sprekelsen, M., Bhattacharyya, N., Chandra, R. K., et al. (2016) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21695 · Cited by 892
Haworth, C. S., Banks, J., Capstick, T., Fisher, A. J., Gorsuch, T., Laurenson, I. F., Leitch, A., Loebinger, M. R., Milburn, H. J., Nightingale, M., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210927 · Cited by 785
Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment
Roden, D. M., Harrington, R. A., Poppas, A., & Russo, A. M. (2020) · Circulation · doi:10.1161/circulationaha.120.047521 · Cited by 779
Mercuro, N. J., Yen, C. F., Shim, D. J., Maher, T. R., McCoy, C. M., Zimetbaum, P. J., & Gold, H. S. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1834 · Cited by 698
Azithromycin: Mechanisms of action and their relevance for clinical applications
Parnham, M. J., Haber, V. E., Giamarellos-Bourboulis, E. J., Perletti, G., Verleden, G. M., & Vos, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.003 · Cited by 661
Musher, D. M., & Thorner, A. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1312885 · Cited by 626
Wong, C., Jayaram, L., Karalus, N., Eaton, T., Tong, C., Hockey, H., Milne, D., Fergusson, W., Tuffery, C., Sexton, P., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60953-2 · Cited by 600
Altenburg, J., de Graaff, C. S., Stienstra, Y., Sloos, J. H., van Haren, E. H. J., Koppers, R. J. H., van der Werf, T. S., & Boersma, W. G. (2013) · JAMA · doi:10.1001/jama.2013.1937 · Cited by 518
A new classification system for chronic lung allograft dysfunction
Verleden, G. M., Raghu, G., Meyer, K. C., Glanville, A. R., & Corris, P. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.10.022 · Cited by 503
Brusselle, G. G., VanderStichele, C., Jordens, P., Deman, R., Slabbynck, H., Ringoet, V., Verleden, G., Demedts, I. K., Verhamme, K., Delporte, A., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202698 · Cited by 477
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
Wright, P. M., Seiple, I. B., & Myers, A. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310843 · Cited by 426
Acute pneumonia and the cardiovascular system
Corrales-Medina, V. F., Musher, D. M., Shachkina, S., & Chirinos, J. A. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61266-5 · Cited by 400
Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults
Postma, D. F., van Werkhoven, C. H., van Elden, L. J. R., Thijsen, S. F. T., Hoepelman, A. I. M., Kluytmans, J. A. J. W., Boersma, W. G., Compaijen, C. J., van der Wall, E., Prins, J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406330 · Cited by 376
Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa
Keenan, J. D., Bailey, R. L., West, S. K., Arzika, A. M., Hart, J., Weaver, J., Kalua, K., Mrango, Z., Ray, K. J., Cook, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715474 · Cited by 360
Furtado, R. H. M., Berwanger, O., Fonseca, H. A., Corrêa, T. D., Ferraz, L. R., Lapa, M. G., Zampieri, F. G., Veiga, V. C., Azevedo, L. C. P., Rosa, R. G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31862-6 · Cited by 360
Traveler’s Diarrhea: A Clinical Review
Steffen, R., Hill, D. R., & DuPont, H. L. (2015) · JAMA · doi:10.1001/jama.2014.17006 · Cited by 349
Saleh, M., Gabriels, J., Chang, D., Soo Kim, B., Mansoor, A., Mahmood, E., Makker, P., Ismail, H., Goldner, B., Willner, J., et al. (2020) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008662 · Cited by 340
Sanchez, E., Vannier, E., Wormser, G. P., & Hu, L. T. (2016) · JAMA · doi:10.1001/jama.2016.2884 · Cited by 337
Schwartz, P. J., & Woosley, R. L. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.063 · Cited by 328
Pharmaco-Immunomodulatory Therapy in COVID-19
Rizk, J. G., Kalantar-Zadeh, K., Mehra, M. R., Lavie, C. J., Rizk, Y., & Forthal, D. N. (2020) · Drugs · doi:10.1007/s40265-020-01367-z · Cited by 288
Adjunctive Azithromycin Prophylaxis for Cesarean Delivery
Tita, A. T. N., Szychowski, J. M., Boggess, K., Saade, G., Longo, S., Clark, E., Esplin, S., Cleary, K., Wapner, R., Letson, K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602044 · Cited by 287
Management of bronchiectasis in adults
Chalmers, J. D., Aliberti, S., & Blasi, F. (2015) · European Respiratory Journal · doi:10.1183/09031936.00119114 · Cited by 286
Prespecified Falsification End Points: Can They Validate True Observational Associations?
Prasad, V., & Jena, A. B. (2013) · JAMA · doi:10.1001/jama.2012.96867 · Cited by 283
Principles of Judicious Antibiotic Prescribing for Upper Respiratory Tract Infections in Pediatrics
Hersh, A. L., Jackson, M. A., Hicks, L. A., the COMMITTEE ON INFECTIOUS DISEASES, Brady, M. T., Byington, C. L., Davies, H. D., Edwards, K. M., Maldonado, Y. A., Murray, D. L., et al. (2013) · Pediatrics · doi:10.1542/peds.2013-3260 · Cited by 266
Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., Alser, O., Alshammari, T. M., Biedermann, P., Banda, J. M., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30276-9 · Cited by 258
Use of Azithromycin and Death from Cardiovascular Causes
Svanström, H., Pasternak, B., & Hviid, A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300799 · Cited by 254
Bharucha, A. E., Kudva, Y. C., & Prichard, D. O. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00161 · Cited by 252
Luo, D., Cheng, Y., Zhang, H., Ba, M., Chen, P., Li, H., Chen, K., Sha, W., Zhang, C., & Chen, H. (2020) · BMJ · doi:10.1136/bmj.m3222 · Cited by 234
Medical Therapies for Adult Chronic Sinusitis: A Systematic Review
Rudmik, L., & Soler, Z. M. (2015) · JAMA · doi:10.1001/jama.2015.7544 · Cited by 166
Macrolide Antibiotics and the Risk of Cardiac Arrhythmias
Albert, R. K., & Schuller, J. L. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0385ci · Cited by 163
“In response to a recently published observational study (1), the FDA warned that azithromycin can change the electrical activity of the heart and reiterated a 2011 product label revision stating that patients with risk factors were at particular risk and strengthened the Warnings and Precautions section of azithromyci…”
BackgroundResultInfluentialPouwels, K. B., Hopkins, S., Llewelyn, M. J., Walker, A. S., McNulty, C. A., & Robotham, J. V. (2019) · BMJ · doi:10.1136/bmj.l440 · Cited by 126
Current views on chronic rejection after lung transplantation
Verleden, G. M., Vos, R., Vanaudenaerde, B., Dupont, L., Yserbyt, J., Van Raemdonck, D., & Verleden, S. (2015) · Transplant International · doi:10.1111/tri.12579 · Cited by 92
The enhancement of cardiac toxicity by concomitant administration of berberine and macrolides
Zhi, D., Feng, P.-F., Sun, J.-L., Guo, F., Zhang, R., Zhao, X., & Li, B.-X. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.05.009 · Cited by 45
Melatonin can attenuate ciprofloxacin induced nephrotoxicity: Involvement of nitric oxide and TNF-α
Shaki, F., Ashari, S., & Ahangar, N. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.053 · Cited by 30
Metadata
- Authors
- Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G., & Stein, C. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-05-17
- Volume
- 366
- Issue
- 20
- Pages
- 1881-1890
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2119425860
- Cited by
- 954
- References
- 37
- FWCI
- 63.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.